Due a lack of controlled study data demonstrating the safety of buprenorphine for use by pregnant women, the FDA has not yet approved
buprenorphine for use by pregnant women unless the
benefits of its use outweigh the potential harms of non use. When doctors choose to prescribe buprenorphine to pregnant women, they will customarily prescribe Subutex (buprenorphine only) rather than Suboxone (buprenorphine and naloxone), to reduce the risks of precipitated withdrawal on the fetus.